Literature DB >> 9372012

The Ras signaling pathway and the molecular basis of myeloid leukemogenesis.

K Shannon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 9372012     DOI： 10.1097/00062752-199502040-00011

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN： 1065-6251            Impact factor:   3.284


× No keyword cloud information.
  7 in total

1.  Loss of wild-type Kras promotes activation of all Ras isoforms in oncogenic Kras-induced leukemogenesis.

Authors:  G Kong; Y-I Chang; A Damnernsawad; X You; J Du; E A Ranheim; W Lee; M-J Ryu; Y Zhou; Y Xing; Q Chang; C E Burd; J Zhang
Journal:  Leukemia       Date:  2016-02-29       Impact factor: 11.528

2.  Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways.

Authors:  Jing Zhang; Yangang Liu; Caroline Beard; David A Tuveson; Rudolf Jaenisch; Tyler E Jacks; Harvey F Lodish
Journal:  Blood       Date:  2007-02-22       Impact factor: 22.113

3.  Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition.

Authors:  Craig Dorrell; Katsuto Takenaka; Mark D Minden; Robert G Hawley; John E Dick
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

4.  Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.

Authors:  Jing Zhang; Jing Wang; Yangang Liu; Harwin Sidik; Ken H Young; Harvey F Lodish; Mark D Fleming
Journal:  Blood       Date:  2008-12-09       Impact factor: 22.113

Review 5.  Aberrant cytokine signaling in leukemia.

Authors:  R A Van Etten
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

6.  Application of targeted next generation sequencing for the mutational profiling of patients with acute lymphoblastic leukemia.

Authors:  Dragana Janic; Jelena Peric; Teodora Karan-Djurasevic; Tatjana Kostic; Irena Marjanovic; Bojana Stanic; Nadja Pejanovic; Lidija Dokmanovic; Jelena Lazic; Nada Krstovski; Marijana Virijevic; Dragica Tomin; Ana Vidovic; Nada Suvajdzic-Vukovic; Sonja Pavlovic; Natasa Tosic
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

7.  In Vitro Apoptotic Effects of Farnesyltransferase blockade in Acute Myeloid Leukemia Cells.

Authors:  V Giudice; P Ricci; L Marino; M Rocco; G Villani; M Langella; L Manente; E Seneca; I Ferrara; L Pezzullo; B Serio; C Selleri
Journal:  Transl Med UniSa       Date:  2016-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.